| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NEUP.12316 |
| P698 | PubMed publication ID | 27388534 |
| P2093 | author name string | Ulrich Sure | |
| Yuan Zhu | |||
| Kathy Keyvani | |||
| Nicolai El Hindy | |||
| Oliver Mueller | |||
| I Erol Sandalcioglu | |||
| Stefanie Wolf | |||
| Daniela Pierscianek | |||
| Klaus-Peter Stein | |||
| P2860 | cites work | The VEGF pathway in lung cancer | Q38148460 |
| Dll4-Notch signaling in regulation of tumor angiogenesis | Q38151514 | ||
| Imaging diagnosis and the role of endovascular embolization treatment for vascular intraspinal tumors | Q38559295 | ||
| Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy | Q38599484 | ||
| VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner | Q38910296 | ||
| Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis | Q40191493 | ||
| The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway | Q40252238 | ||
| Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. | Q40290961 | ||
| EphB4 controls blood vascular morphogenesis during postnatal angiogenesis | Q40327178 | ||
| Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor | Q40396846 | ||
| Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo | Q43549436 | ||
| Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. | Q51792931 | ||
| The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study | Q52147874 | ||
| p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk | Q53651797 | ||
| Von Hippel-Lindau disease. | Q54863226 | ||
| Notch signaling is essential for ventricular chamber development | Q24299001 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside | Q26770678 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function | Q28140184 | ||
| The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract | Q28504884 | ||
| Notch1 functions as a tumor suppressor in mouse skin | Q29614987 | ||
| EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling | Q30479634 | ||
| Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells | Q33730124 | ||
| Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis | Q33752236 | ||
| Overexpression and activation of epidermal growth factor receptor in hemangioblastomas | Q34083790 | ||
| Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases | Q34562505 | ||
| Sporadic hemangioblastomas are characterized by cryptic VHL inactivation | Q34979062 | ||
| Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma | Q35173651 | ||
| Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer | Q35600870 | ||
| Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma | Q35816668 | ||
| The double-edged sword of Notch signaling in cancer | Q35989577 | ||
| Erythropoietin Stimulates Tumor Growth via EphB4. | Q36275814 | ||
| Notch receptor and effector expression in von Hippel-Lindau disease–associated central nervous system hemangioblastomas | Q36602728 | ||
| Current status and future directions of anti-angiogenic therapy for gliomas | Q36618235 | ||
| Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth | Q36705891 | ||
| Angiogenesis in brain tumours | Q36887534 | ||
| Clinical implications of DLL4 expression in gastric cancer | Q37114635 | ||
| Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme | Q37187681 | ||
| Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma | Q37231081 | ||
| Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene | Q37285776 | ||
| Angiogenesis: a team effort coordinated by notch. | Q37393190 | ||
| Dll4-Notch signaling as a therapeutic target in tumor angiogenesis | Q37933528 | ||
| The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. | Q38058991 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3-11 | |
| P577 | publication date | 2016-07-07 | |
| P1433 | published in | Neuropathology | Q15761930 |
| P1476 | title | Study of angiogenic signaling pathways in hemangioblastoma | |
| P478 | volume | 37 |
| Q48194235 | Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway |
| Q41520269 | EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation |
| Q52331402 | Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes |
| Q88938326 | Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation |
| Q89843928 | Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors |
| Q89052192 | Role of Endothelial-to-Mesenchymal Transition in the Pathogenesis of Central Nervous System Hemangioblastomas |
| Q64074421 | von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME |
Search more.